🇺🇸 Liposomal bupivacaine plus bupivacaine in United States

Liposomal bupivacaine plus bupivacaine (Liposomal bupivacaine plus bupivacaine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Liposomal bupivacaine plus bupivacaine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Liposomal bupivacaine plus bupivacaine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Liposomal bupivacaine plus bupivacaine in United States?

Beijing Tiantan Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.